Rutgers researchers create tiny chemical cages to enclose drug, pesticide molecules

Tiny chemical cages created by researchers at Rutgers, The State University of New Jersey, show potential for delivering drugs to organs or tissues where they're needed without causing harm elsewhere.

These cage-like molecules, called nanocontainers or nanoscale capsules because they measure a mere 3.2 nanometers (billionths of a meter) wide, also could make pesticides less hazardous to handle, filter toxic substances out of wastewater and regulate the pace of reactions in chemical production.

"While the concept of chemical cages is not new, we've created new components and advanced the assembly process to increase the chance that they'll become practical," said Ralf Warmuth, associate professor of chemistry and chemical biology at Rutgers and lead researcher. "We've shown a way to securely link molecules together in a cage using an efficient, one-step process."

In an article slated for an upcoming issue of the chemistry journal Angewandte Chemie International Edition, now available on the journal's Web site at www3.interscience.wiley.com/cgi-bin/fulltext/112223539/PDFSTART, Warmuth and colleagues describe how they've used common organic chemicals and straightforward techniques to create nanocontainers. These octahedral (eight-sided) capsules, with their cavity volume of almost two cubic nanometers, could enclose one or more molecules of a medicine, pesticide or intermediate in a chemical manufacturing process that, if left uncaged, might prematurely decay or interact with other substances in passing.

Previous techniques for assembling molecular cages involved tradeoffs. With one approach, the synthesis technique was straightforward, but the pieces of the molecular cages were not bound as tightly to each other. Another approach resulted in tighter bonds, but the process required several carefully orchestrated steps. The Rutgers advance is a one-step p

Contact: Carl Blesch
732-932-7084 x616
Rutgers, the State University of New Jersey

Page: 1 2

Related biology news :

1. Role of thyroid hormones in slumber under investigation at Rutgers
2. Rutgers, Penn researchers capture research dollars to improve prostate cancer diagnostic methods
3. Rutgers: GM/GMO/Biotech crop containment strategy
4. National Academy of Sciences elects 2 Rutgers professors
5. NSF funds new Rutgers plant biomaterials initiative
6. Rutgers survey examines public responses to the recent spinach recall
7. Rutgers College of Nursing dean authors a book on genetics and how it affects nursing and health
8. Rutgers anthropologist to receive Crafoord Prize, biologys equivalent of Nobel Prize
9. NSF funds biofertilizer research at Rutgers-Camden
10. Icelandic volcano caused historic famine in Egypt, says Rutgers-based team
11. Rutgers-led group lands $2.55 million to advance high school biology and math

Post Your Comments:

(Date:7/20/2017)... Delta (NYSE: DAL ) customers now can use fingerprints instead ... National Airport (DCA). ... Delta launches biometrics to board aircraft at Reagan Washington National Airport ... Delta,s biometric boarding pass experience that launched in ... the boarding process to allow eligible Delta SkyMiles Members who are enrolled ...
(Date:6/14/2017)... (NYSE: IBM ) is introducing several innovative partner startups ... collaboration between startups and global businesses, taking place in ... nine startups will showcase the solutions they have built with ... France is one of the ... percent increase in the number of startups created between 2012 ...
(Date:5/16/2017)... May 16, 2017   Bridge Patient Portal ... and MD EMR Systems , an electronic ... for GE, have established a partnership to build ... and the GE Centricity™ products, including Centricity Practice ... These new integrations will allow healthcare ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... , ... October 11, 2017 , ... ... gene in its endogenous context, enabling overexpression experiments and avoiding the use of ... small RNA guides is transformative for performing systematic gain-of-function studies. , This ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... , ... October 10, 2017 ... ... cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing ... HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... process optimization firm for the life sciences and healthcare industries, announces a presentation ... San Francisco. , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will ...
Breaking Biology Technology:
Cached News: